Blog
About

1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Dynamical model for assessment of anti-angiogenic therapy of cancer.

      1 ,

      Molecular bioSystems

      Royal Society of Chemistry (RSC)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Different experimental models have substantially established that the anti-angiogenic (AAG)group of drugs are able to control the growth of tumor mass by cutting down the nutritive supply to the cancer cells. The mechanism of action of this group of drugs acts on the cells of the vascular endothelium. Recently, different AAG drugs have been in clinical trials. Initial clinical trials showed that application of AAG drugs produced different sorts of toxicity in patients,so calibration of the doses and drug application schedules are very important at present.Hence, development of analytical models would definitely help in this respect, particularly atthe individual level. The analytical model presented here may help to make a judicious choice of drug doses and drug schedule to control the growth of the tumor system under the condition of malignancy.

          Related collections

          Author and article information

          Journal
          Mol Biosyst
          Molecular bioSystems
          Royal Society of Chemistry (RSC)
          1742-2051
          1742-2051
          Jun 2010
          : 6
          : 6
          Affiliations
          [1 ] Department of Computer Science & Technology, Bengal Engineering & Science University, Shibpur, Botanic Garden, Howrah 711103, West Bengal, India.
          10.1039/b917545h
          20358121

          Comments

          Comment on this article